Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

Completed · Phase 2

Conditions studied: Hypertriglyceridemia

In brief

Pharmacodynamic effects of MAT9001 compared to Vascepa in adults with hypertriglyceridemia

Key facts

Study ID
NCT04177680
Run by
Matinas BioPharma Nanotechnologies, Inc.
People needed
100
Starts
2020-06-03
Expected to finish
2021-01-18
Last updated by the study team
2022-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.